Tamara Maes
Founder at ORYZON GENOMICS S.A.
Net worth: 5 M $ as of 2024-03-30
Profile
Tamara Maes is the founder of Oryzon Genomics SA, which was founded in 2000.
She currently holds the position of First Deputy Chairman at Oryzon Genomics SA. Dr. Maes is also currently working as a Director at Mendelion Lifesciences SL, a Member at the Alzheimers Drug Discovery Foundation, and a Scientific Coordinator at Oncnosis Pharma AIE.
Dr. Maes obtained a doctorate degree from Ghent University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ORYZON GENOMICS SA
4.08% | 2022-12-30 | 2,528,398 ( 4.08% ) | 5 M $ | 2024-03-30 |
Tamara Maes active positions
Companies | Position | Start |
---|---|---|
ORYZON GENOMICS S.A. | Founder | 2000-06-01 |
Oncnosis Pharma AIE | Corporate Officer/Principal | - |
Mendelion Lifesciences SL
Mendelion Lifesciences SL Engineering & ConstructionIndustrial Services Mendelion Lifesciences SL constructs commercial buildings. | Director/Board Member | - |
Alzheimers Drug Discovery Foundation
Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr. | Corporate Officer/Principal | 2015-12-31 |
Training of Tamara Maes
Ghent University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ORYZON GENOMICS S.A. | Health Technology |
Private companies | 3 |
---|---|
Alzheimers Drug Discovery Foundation
Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr. | Health Technology |
Oncnosis Pharma AIE | |
Mendelion Lifesciences SL
Mendelion Lifesciences SL Engineering & ConstructionIndustrial Services Mendelion Lifesciences SL constructs commercial buildings. | Industrial Services |
- Stock Market
- Insiders
- Tamara Maes